Hikma Pharmaceutical reported 358.07B in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Almirall ALM:SM 2.07B 41.35M
Argen X Bv ARGX:BB 15.15B 912.65M
Artemis Alpha ATS:LN 169M 15.29M
AstraZeneca AZN:LN 156.99B 22.53B
Bayer BAYN:GR 61.51B 15.23B
Fresenius FRE:GR 18.62B 1.15B
Fresenius Medical Care FMS:US 19.7B 0.74B
Galapagos GLPG:NA 3.7B 469.49M
Genmab GEN:DC 162.03B 10.8B
GlaxoSmithKline GSK:LN 83.74B 2.9B
H. Lundbeck A/S LUN:DC 31B 2.63B
Hikma Pharmaceutical HIK:LN 5.14B 524.89M
Lonza Group LONN:SW 56.72B 7.88B
Merck MRK:GR 24.54B 4.87B
Orion ORNBV:FH 5.8B 661.12M
Recordati REC:IM 9.54B 2.27B
Roche Holding ROG:VX 300.5B 1.25B
Sanofi SAN:FP 116.9B 4.98B
UCB UCB:BB 19.52B 2.37B